Travere Therapeutics
TVTX
TVTX
168 hedge funds and large institutions have $737M invested in Travere Therapeutics in 2023 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 65 increasing their positions, 49 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
32% less call options, than puts
Call options by funds: $14M | Put options by funds: $20.6M
42% less capital invested
Capital invested by funds: $1.27B → $737M (-$536M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
168
Holding in Top 10
1
Calls
$14M
Puts
$20.6M
Top Buyers
| 1 | +$24.4M | |
| 2 | +$23.5M | |
| 3 | +$12.9M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$11.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$9.93M |
Top Sellers
| 1 | -$62M | |
| 2 | -$32.5M | |
| 3 | -$15.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$12M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$7.6M |